Literature DB >> 9360565

Restraint position and positional asphyxia.

T C Chan1, G M Vilke, T Neuman, J L Clausen.   

Abstract

STUDY
OBJECTIVE: To determine whether the "hobble" or "hog-tie" restraint position results in clinically relevant respiratory dysfunction.
METHODS: This was an experimental, crossover, controlled trial at a university-based pulmonary function laboratory involving 15 healthy men ages 18 through 40 years. Subjects were excluded for a positive urine toxicology screen, body mass index (BMI) greater than 30 kg/m2, or abnormal screening pulmonary function testing (PFT). Forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), and maximal voluntary ventilation (MVV) were obtained with subjects in the sitting, supine, prone, and restraint positions. After a 4-minute exercise period, subjects rested in the sitting position while pulse, oxygen saturation, and arterial blood gases were monitored. The subjects repeated the exercise, then were placed in the restraint position with similar monitoring.
RESULTS: There was a small, statistically significant decline in the mean FVC (from 5.31 +/- 1.01 L [101% +/- 10.5% of predicted] to 4.60 +/- .84 L [88% +/- 8.8% of predicted]), mean FEV1 (from 4.31 +/- .53 L [103% +/- 8.4%] to 3.70 +/- .45 L [89% +/- 7.7%]), and mean MVV (from 165.5 +/- 24.5 L/minute [111% +/- 17.3%] to 131.1 +/- 20.7 L/minute [88% +/- 16.6%]), comparing sitting with restraint position (all, P < .001). There was no evidence of hypoxia (mean oxygen tension [PO2] less than 95 mm Hg or co-oximetry less than 96%) in either position. The mean carbon dioxide tension (PCO2) for both groups was not different after 15 minutes of rest in the sitting versus the restraint position. There was no significant difference in heart rate recovery or oxygen saturation as measured by co-oximetry and pulse oximetry.
CONCLUSION: In our study population of healthy subjects, the restraint position resulted in a restrictive pulmonary function pattern but did not result in clinically relevant changes in oxygenation or ventilation.

Entities:  

Mesh:

Year:  1997        PMID: 9360565     DOI: 10.1016/s0196-0644(97)70072-6

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  10 in total

Review 1.  Drug abusers who die during arrest or in custody.

Authors:  S B Karch; B G Stephens
Journal:  J R Soc Med       Date:  1999-03       Impact factor: 5.344

2.  Overwhelming number of AA deaths occur in police custody.

Authors:  Pamela E Southall; Joseph P Pestaner
Journal:  J Natl Med Assoc       Date:  2003-08       Impact factor: 1.798

3.  Acute excited states and sudden death.

Authors:  H G Kennedy; F R Farnham
Journal:  BMJ       Date:  1998-10-24

Review 4.  Death by restraint.

Authors:  D Milliken
Journal:  CMAJ       Date:  1998-06-16       Impact factor: 8.262

Review 5.  'Excited Delirium', acute behavioural disturbance, death and diagnosis.

Authors:  Terry McGuinness; Maurice Lipsedge
Journal:  Psychol Med       Date:  2022-05-12       Impact factor: 10.592

6.  Excited delirium.

Authors:  Asia Takeuchi; Terence L Ahern; Sean O Henderson
Journal:  West J Emerg Med       Date:  2011-02

7.  A "Necessary Evil": Staff Perspectives of Soft Restraint Kit Use in a High-Security Hospital.

Authors:  Helen Walker; Lindsay Tulloch
Journal:  Front Psychiatry       Date:  2020-05-14       Impact factor: 4.157

Review 8.  The role of restraint in fatal excited delirium: a research synthesis and pooled analysis.

Authors:  Ellen M F Strömmer; Wendy Leith; Maurice P Zeegers; Michael D Freeman
Journal:  Forensic Sci Med Pathol       Date:  2020-08-22       Impact factor: 2.007

9.  Prone restraint cardiac arrest in in-custody and arrest-related deaths.

Authors:  Victor Weedn; Alon Steinberg; Pete Speth
Journal:  J Forensic Sci       Date:  2022-07-22       Impact factor: 1.717

Review 10.  Restraint physiology: A review of the literature.

Authors:  Gary M Vilke
Journal:  J Forensic Leg Med       Date:  2020-09-15       Impact factor: 1.614

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.